COPD patients with and without metabolic syndrome: clinical and functional differences-Reference-Cited by-同舟云学术

COPD patients with and without metabolic syndrome: clinical and functional differences

Published:2013-05-05 Issue:4 Volume:9 Page:419-425
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Díez-Manglano Jesús, ,Barquero-Romero José,Almagro Pedro,Cabrera Francisco Javier,López García Francisco,Montero Lorena,Soriano Joan Baptiste

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11739-013-0945-7.pdf

Reference34 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2011) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2011). Available from: http://www.goldcopd.com

2. World Health Organization. World Health Statistics 2008. Part 1. Ten highlights in health statistics. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Part1.pdf

3. Finkelstein J, Cha E, Scharf SM (2009) Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 4:337–349

4. World Health Organization. Regional Office for Europe. Obesity. Available from: http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/obesity

5. Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review;Molecular and Cellular Biochemistry;2024-09-10

2. Integrative Approach to Risk Factors in Simple Chronic Obstructive Airway Diseases of the Lung or Associated with Metabolic Syndrome—Analysis and Prediction;Nutrients;2024-06-13

3. Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based Cohort Study;International Journal of Chronic Obstructive Pulmonary Disease;2024-06

4. Comorbidities in COPD: Current and Future Treatment Challenges;Journal of Clinical Medicine;2024-01-27

5. Impact of comorbidities in COPD clinical control criteria. The CLAVE study;BMC Pulmonary Medicine;2024-01-02